Differential gene expression in chemically induced mouse lung adenomas

Neoplasia

Volumn 5, Issue 1, 2003, Pages 41-52

  Yao, Ruisheng ^a   Wang, Yian ^a   Lubet, Ronald A ^b   You, Ming ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer genes; CCLS; Differential changes; Expression profile; Lung adenomas

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA ADAPTIN; ALPHA GLOBIN; BETA GLOBIN; COMPLEMENTARY DNA; CYTOCHROME P450 2C40; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HELIX LOOP HELIX PROTEIN; HELIX LOOP HELIX UBIQUITOUS KINASE; JANUS KINASE; MESSENGER RNA; METHYLNITROSOUREA; MITOGEN ACTIVATED PROTEIN KINASE 1; PAROXANASE; PROTEIN FLJ11240; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; THIOETHER S METHYLTRANSFERASE; TRANSCRIPTION FACTOR NFAT; TUMOR MARKER; UNCLASSIFIED DRUG; VON EBNER SALIVARY GLAND PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; DOT HYBRIDIZATION; FEMALE; GENE EXPRESSION; LUNG ADENOMA; LUNG CARCINOGENESIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0037252353     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(03)80016-7     Document Type: Article

References (46)

1. Beckett WS (1993). Epidemiology and etiology of lung cancer. Clin Chest Med 14, 1-15.
2. Fielding JE (1985). Smoking: health effects and control (1). N Engl J Med 313, 491-98.
3. Herzog CR, Lubet RA, and You M (1997). Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J Cell Biochem Suppl 28-29, 49-63.
4. Witschi H, Espiritu I, Maronpot RR, Pinkerton KE, and Jones AD (1997). The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis 18, 2035-42.
5. Witschi H, Espiritu I, Peake JL, Wu K, Maronpot RR, and Pinkerton KE (1997). The carcinogenicity of environmental tobacco smoke. Carcinogenesis 18, 575-86.
6. Malkinson AM (1992). Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res 52, 2670s-76s.
7. You M, Candrian U, Maronpot RR, Stoner GD, and Anderson MW (1989). Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 86, 3070-74.
8. Re FC, Manenti G, Borrello MG, Colombo MP, Fisher JH, Pierotti MA, Della Porta G, and Dragani TA (1992). Multiple molecular alterations in mouse lung tumors. Mol Carcinog 5, 155-60.
9. Herzog CR, Wang Y, and You M (1995). Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene 11, 1811 -15.
10. Herzog CR, Chen B, Wang Y, Schut HA, and You M (1996). Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas. Mol Carcinog 16, 83-90.
11. Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, and Wiseman RW (1994). Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 54, 6257-64.
12. Wang Y, Hu L, Yao R, Wang M, Crist KA, Grubbs CJ, Johanning GL, Lubet RA, and You M (2001). Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor. Oncogene 20, 7710-21.
13. Joneson T, and Bar-Sagi D (1997). Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med 75, 587-93.
14. Wolthuis RM, and Bos JL (1999). Ras caught in another affair: the exchange factors for Ral. Curr Opin Genet Dev 9, 112-17.
15. Okazaki M, Kishida S, Hinoi T, Hasegawa T, Tamada M, Kataoka T, and Kikuchi A (1997). Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator. Oncogene 14, 515-21.
16. Gille H, and Downward J (1999). Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem 274, 22033-40.
17. Johnson SA, Mandavia N, Wang HD, and Johnson DL (2000). Transcriptional regulation of the TATA-binding protein by Ras cellular signaling. Mol Cell Biol 20, 5000-5009.
18. Ward Y, Wang W, Woodhouse E, Linnoila I, Liotta L, and Kelly K (2001). Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol Cell Biol 21, 5958-69.
19. Price DT, Rocca GD, Guo C, Ballo MS, Schwinn DA, and Luttrell LM (1999). Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 162, 1537-42.
20. Connelly MA, and Marcu KB (1995). CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain. Cell Mol Biol Res 41, 537-49.
21. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, and Rothe M (1997). Identification and characterization of an IkappaB kinase. Cell 90, 373-83.
22. Boguski MS, and McCormick F (1993). Proteins regulating Ras and its relatives. Nature 366, 643-54.
23. Trahey M, Wong G, Halenbeck R, Rubinfeld B, Martin GA, Ladner M, Long CM, Crosier WJ, Watt K, Koths K, and McCormick F (1998). Molecular cloning of two types of GAP complementary DNA from human placenta. Science 242, 1697-700.
24. Vleurick L, Pezet A, Kuhn ER, Decuypere E, and Edery M (1999). A beta-turn endocytic code is required for optimal internalization of the growth hormone receptor but not for alpha-adaptin association. Mol Endocrinol 13, 1823-31.
25. Okabayashi Y, Sugimoto Y, Tolty NF, Hsuan J, Kido Y, Sakaguchi K, Gout I, Waterfield MD, and Kasuga M (1996). Interaction of Shc with adaptor protein adaptins. J Biol Chem 271, 5265-69.
26. Viola JP, and Rao A (1997). Role of the cyclosporin-sensitive transcription factor NFAT1 in the allergic response. Mern Inst Oswaldo Cruz 92(Suppl 2), 147-55.
27. Erlanson DA, Chytil M, and Verdine GL (1996). The leucine zipper domain controls the orientation of AP-1 in the NFAT.AP-1.DNA complex. Chem Biol 3, 981-91.
28. Sune C, and Garcia-Blanco MA (1999). Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner. Mol Cell Biol 19, 4719-28.
29. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS, and Lau LF (1997). Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 233, 63-77.
30. Kolesnikova TV, and Lau LF (1998). Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 16, 747-54.
31. Kireeva ML, Lam SC, and Lau LF (1998). Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J Biol Chem 273, 3090-96.
32. Babic AM, Kireeva ML, Kolesnikova TV, and Lau LF (1998). CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95, 6355-60.
33. Waheed A, Zhu XL, and Sly WS (1992). Membrane-associated carbonic anhydrase from rat lung. Purification, characterization, tissue distribution, and comparison with carbonic anhydrase IVs of other mammals. J Biol Chem 267, 3308-11.
34. Lonnerholm G, and Wistrand PJ (1991). Membrane-bound carbonic anhydrase CA IV in the human kidney. Acta Physiol Scand 141, 231-34.
35. Christie KN, Thomson C, Xue L, Lucocq JM, and Hopwood D (1997). Carbonic anhydrase isoenzymes I, II, III, and IV are present in human esophageal epithelium. J Histochem Cytochem 45, 35-40.
36. Dockham PA, Lee MO, and Sladek NE (1992). Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem Pharmacol 43, 2453-69.
37. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, Tschopp J, and French LE (1999). Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112, 290-96.
38. Sintich SM, Steinberg J, Kozlowski JM, Lee C, Pruden S, Sayeed S, and Sensibar JA (1999). Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin). Prostate 39, 87-93.
39. Lodish H, Baltimore D, Berk A, Zipurski SL, Matsudaira P, and Darnell J (1995). Molecular Cell Biology (3rd ed), W.H. Freeman, New York.
40. Singh G, Singh J, Katyal SL, Brown WE, Kramps JA, Paradis IL, Dauber JH, Macpherson TA, and Squeglia N (1988). Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem 36, 73-80.
41. Andersson O, Nordlund-Moller L, Barnes HJ, and Lund J (1994). Heterologous expression of human uterogrobin/polychlorinated biphenyl-binding protein. Determination of ligand binding parameters and mechanism of phospholipase A2 inhibition in vitro. J Biol Chem 269, 19081-87.
42. Szabo E, Goheer A, Witschi H, and Linnoila RI (1998). Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ 9, 475-85.
43. Weaver TE, and Whitsett JA (1991). Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J 273, 249-64, Part 2.
44. Pilling AM, Mifsud NA, Jones SA, Endersby-Wood HJ, and Turton JA (1999). Expression of surfactant protein mRNA in normal and neoplastic lung of B6C3F1 mice as demonstrated by in situ hybridization. Vet Pathol 36, 57-63.
45. Mason RJ, Kalina M, Nielsen LD, Malkinson AM, and Shannon JM (2000). Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol 156, 175-82.
46. Ramakrishna G, Perella C, Birely L, Diwan BA, Fornwald LW, and Anderson LM (2002). Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N.-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 179, 21-34.